Asian Phytoceuticals Public Co., Ltd.(TH:APCO)
฿2.50-0.02 (-0.79%)
TH:APCO
Asian Phytoceuticals Public Co., Ltd. financials statements
฿2.50
At close:-0.02 (-0.79%)
Asian Phytoceuticals Public Co., Ltd. (APCO) Ratios
Asian Phytoceuticals Public Co., Ltd. Ratios
TH:APCO's free cash flow for Q2 2026 was ฿3.76M. For the 2026 fiscal year, TH:APCO's free cash flow was decreased by ฿-620.19K and operating cash flow was ฿4.38M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 10.85 | 10.75 | 6.51 | 5.27 | 4.84 |
| Quick Ratio | 9.14 | 9.28 | 5.55 | 4.10 | 3.61 |
| Cash Ratio | 2.54 | 1.61 | 2.72 | 1.82 | 2.06 |
| Solvency Ratio | 1.06 | 0.99 | 1.40 | 1.50 | 1.12 |
| Operating Cash Flow Ratio | 1.49 | 0.97 | 2.69 | 2.22 | 1.77 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | ฿ 367.07M | ฿ 339.23M | ฿ 208.48M | ฿ 167.87M | ฿ 145.57M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.02 | 0.04 | 0.05 | 0.02 | 0.05 |
| Debt-to-Equity Ratio | 0.02 | 0.04 | 0.06 | 0.02 | 0.06 |
| Debt-to-Capital Ratio | 0.02 | 0.04 | 0.06 | 0.02 | 0.05 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.13 | 1.14 | 1.16 | 1.12 | 1.14 |
| Debt Service Coverage Ratio | 37.26 | 47.94 | 198.93 | 162.48 | 97.18 |
| Interest Coverage Ratio | 33.23 | 33.34 | 176.77 | 155.47 | 85.41 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.03 | 0.04 | 0.06 | 0.02 | 0.06 |
| Net Debt to EBITDA | -1.21 | -0.43 | -0.58 | -0.61 | -0.64 |
| Profitability Margins | |||||
| Gross Profit Margin | 84.44% | 80.57% | 80.45% | 80.85% | 79.29% |
| EBIT Margin | 26.77% | 32.20% | 45.72% | 35.16% | 33.05% |
| EBITDA Margin | 36.58% | 42.01% | 53.28% | 44.44% | 45.12% |
| Operating Profit Margin | 26.77% | 25.19% | 39.93% | 35.16% | 33.05% |
| Pretax Profit Margin | 34.85% | 32.24% | 45.49% | 40.13% | 38.28% |
| Net Profit Margin | 27.68% | 25.95% | 36.72% | 32.32% | 30.76% |
| Continuous Operations Profit Margin | 28.28% | 26.45% | 37.14% | 32.19% | 30.89% |
| Net Income Per EBT | 79.45% | 80.48% | 80.71% | 80.53% | 80.36% |
| EBT Per EBIT | 130.17% | 128.00% | 113.94% | 114.13% | 115.81% |
| Return on Assets (ROA) | 8.78% | 8.60% | 15.25% | 11.90% | 10.09% |
| Return on Equity (ROE) | 9.95% | 9.83% | 17.63% | 13.31% | 11.55% |
| Return on Capital Employed (ROCE) | 9.07% | 8.89% | 17.75% | 13.86% | 11.67% |
| Return on Invested Capital (ROIC) | 7.22% | 7.14% | 14.20% | 10.99% | 9.10% |
| Return on Tangible Assets | 8.79% | 8.61% | 15.27% | 11.90% | 10.10% |
| Earnings Yield | 3.23% | 1.85% | 3.48% | 2.70% | 1.80% |
| Efficiency Ratios | |||||
| Receivables Turnover | 53.13 | 38.40 | 69.33 | 59.47 | 67.96 |
| Payables Turnover | 30.74 | 53.50 | 47.78 | 75.40 | 23.22 |
| Inventory Turnover | 0.45 | 0.72 | 1.29 | 0.91 | 0.79 |
| Fixed Asset Turnover | 4.17 | 3.17 | 3.56 | 3.91 | 2.45 |
| Asset Turnover | 0.32 | 0.33 | 0.42 | 0.37 | 0.33 |
| Working Capital Turnover Ratio | 0.52 | 0.67 | 1.31 | 1.33 | 1.19 |
| Cash Conversion Cycle | 804.32 | 510.83 | 279.91 | 400.98 | 452.09 |
| Days of Sales Outstanding | 6.87 | 9.51 | 5.26 | 6.14 | 5.37 |
| Days of Inventory Outstanding | 809.33 | 508.15 | 282.29 | 399.69 | 462.44 |
| Days of Payables Outstanding | 11.87 | 6.82 | 7.64 | 4.84 | 15.72 |
| Operating Cycle | 816.20 | 517.65 | 287.55 | 405.83 | 467.81 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.10 | 0.06 | 0.21 | 0.17 | 0.14 |
| Free Cash Flow Per Share | 0.10 | 0.06 | 0.20 | 0.17 | 0.14 |
| Dividend Paid and CapEx Coverage Ratio | 1.07 | 0.34 | 1.28 | 1.35 | 1.15 |
| Capital Expenditure Coverage Ratio | 75.19 | 16.31 | 30.28 | 310.97 | 71.86 |
| Operating Cash Flow Coverage Ratio | 4.40 | 1.56 | 3.48 | 7.25 | 2.47 |
| Operating Cash Flow to Sales Ratio | 0.30 | 0.18 | 0.42 | 0.40 | 0.38 |
| Free Cash Flow Yield | 3.45% | 1.20% | 3.88% | 3.33% | 2.18% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 30.95 | 53.95 | 28.61 | 38.46 | 57.73 |
| Price-to-Sales (P/S) Ratio | 8.57 | 14.00 | 10.55 | 11.98 | 17.06 |
| Price-to-Book (P/B) Ratio | 3.08 | 5.30 | 5.07 | 4.93 | 6.40 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 28.95 | 83.49 | 25.74 | 30.04 | 45.78 |
| Price-to-Operating Cash Flow Ratio | 28.56 | 78.37 | 24.89 | 29.95 | 45.14 |
| Price-to-Earnings Growth (PEG) Ratio | 23.52 | -1.09 | 0.74 | 2.12 | -6.93 |
| Enterprise Value Multiple | 22.22 | 32.89 | 19.23 | 26.35 | 37.17 |
| Enterprise Value | 1.63B | 2.91B | 3.00B | 2.93B | 3.75B |
| EV to EBITDA | 22.22 | 32.89 | 19.23 | 26.35 | 37.17 |
| EV to Sales | 8.13 | 13.82 | 10.24 | 11.71 | 16.77 |
| EV to Free Cash Flow | 27.45 | 82.41 | 24.99 | 29.36 | 45.01 |
| EV to Operating Cash Flow | 27.08 | 77.36 | 24.17 | 29.26 | 44.38 |
| Tangible Book Value Per Share | 0.93 | 0.93 | 1.02 | 1.02 | 0.99 |
| Shareholders’ Equity Per Share | 0.93 | 0.93 | 1.02 | 1.01 | 0.99 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.19 | 0.18 | 0.18 | 0.19 | 0.20 |
| Revenue Per Share | 0.33 | 0.35 | 0.49 | 0.42 | 0.37 |
| Net Income Per Share | 0.09 | 0.09 | 0.18 | 0.13 | 0.11 |
| Tax Burden | 0.79 | 0.80 | 0.81 | 0.81 | 0.80 |
| Interest Burden | 1.30 | 1.00 | 1.00 | 1.14 | 1.16 |
| Research & Development to Revenue | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 |
| SG&A to Revenue | 0.58 | 0.57 | 0.41 | 0.47 | 0.48 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.08 | 0.69 | 1.15 | 1.00 | 0.99 |
Currency in THB
